Clinical Trial - Water Therapy for Autosomal Dominant Polycystic Kidney Disease - Polycystic Kidney Disease
The study will involve 11 visits to the study site over 19 months. Participants will need to follow specific dietary and fluid recommendations. At each visit, patients will go through physical examinations and medical history assessments. Testing will include magnetic resonance imaging (MRI), blood and urine tests. Study participants will be compensated for their time. Interested patients can review detailed study procedures by contacting with the study team.
| Study Type : | Interventional  (Clinical Trial) |
| Estimated Enrollment : | 32 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Sequential Assignment |
| Intervention Model Description: | Participants will have a period of usual fluid intake and a period of increased water intake over the course of the study. |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | The radiologist measuring kidney volumes will be masked to the study condition. |
| Primary Purpose: | Treatment |
| Official Title: | A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease |
| Actual Study Start Date : | June 1, 2017 |
| Estimated Primary Completion Date : | December 2018 |
| Estimated Study Completion Date : | April 2019 |
Contacts
| Contact: Ines G Chicos | 212-746-3541 | inc9012@nyp.org | |
| Contact: Irina Barash, MD, MS | 212-746-9077 | irb9023@nyp.org |
| ClinicalTrials.gov Identifier: | NCT03102632 |
For enrollment please visit www.clinicaltrials.gov.
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.